Abstract
A series of non-peptide competitive antagonists of the human IMR 90 fetal lung fibroblast bradykinin B2 receptor have been designed and synthesized. Compound 15 binds with an affinity constant Ki = 60 nM. The SAR leading to the design of these non-peptide antagonists is described.
Original language | English |
---|---|
Pages (from-to) | 357-362 |
Number of pages | 6 |
Journal | Bioorganic and Medicinal Chemistry Letters |
Volume | 5 |
Issue number | 4 |
DOIs | |
State | Published - Feb 16 1995 |